| Date Filed | Type | Description |
| 08/23/2023 |
4
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 3,724 shares
@ $5.84, valued at
$21.7k
|
|
| 08/11/2023 |
4
| Mitchell Stephen Ray (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 6,500 shares
@ $6.0537, valued at
$39.3k
|
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2023 |
4
| Ward Anne Sempowski (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 17,307 shares
@ $0
Granted 33,960 options to buy
@ $6.5, valued at
$220.7k
|
|
| 06/12/2023 |
4
| Mitchell Stephen Ray (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 17,307 shares
@ $0
Granted 33,960 options to buy
@ $6.5, valued at
$220.7k
|
|
| 06/12/2023 |
4
| Honore Tage (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 17,307 shares
@ $0
Granted 33,960 options to buy
@ $6.5, valued at
$220.7k
|
|
| 06/12/2023 |
4
| DUGAN RICHARD W (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 17,307 shares
@ $0
Granted 33,960 options to buy
@ $6.5, valued at
$220.7k
|
|
| 06/12/2023 |
4
| Chrousos Phaedra (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 17,307 shares
@ $0
Granted 33,960 options to buy
@ $6.5, valued at
$220.7k
|
|
| 03/17/2023 |
4
| Honore Tage (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 26,408 shares
@ $0
Granted 51,276 options to buy
@ $6.39, valued at
$327.7k
|
|
| 03/17/2023 |
3
| Honore Tage (Director) has filed a Form 3 on Vanda Pharmaceuticals Inc. |
| 03/06/2023 |
4
| Williams Timothy (SVP & General Counsel) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 8,437 shares
@ $6.2445, valued at
$52.7k
Sold 8,301 shares
@ $6.2507, valued at
$51.9k
|
|
| 03/06/2023 |
4
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 7,720 shares
@ $6.2335, valued at
$48.1k
Sold 4,113 shares
@ $6.32, valued at
$26k
|
|
| 03/06/2023 |
4
| Polymeropoulos Mihael Hristos (President and CEO) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 22,426 shares
@ $6.2302, valued at
$139.7k
Sold 22,538 shares
@ $6.2506, valued at
$140.9k
|
|
| 03/06/2023 |
4
| Moran Kevin Patrick (SVP, CFO & Treasurer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 7,966 shares
@ $6.2573, valued at
$49.8k
Sold 5,968 shares
@ $6.2833, valued at
$37.5k
|
|
| 03/06/2023 |
4
| Birznieks Gunther (SVP, Business Development) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 8,509 shares
@ $6.2044, valued at
$52.8k
Sold 8,268 shares
@ $6.264, valued at
$51.8k
|
|
| 02/21/2023 |
4
| Williams Timothy (SVP & General Counsel) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 32,700 shares
@ $0
Granted 77,500 options to buy
@ $7.05, valued at
$546.4k
|
|
| 02/21/2023 |
4
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 32,700 shares
@ $0
Granted 77,500 options to buy
@ $7.05, valued at
$546.4k
|
|
| 02/21/2023 |
4
| Polymeropoulos Mihael Hristos (President and CEO) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 115,000 shares
@ $0
Granted 275,000 options to buy
@ $7.05, valued at
$1.9M
|
|
| 02/21/2023 |
4
| Moran Kevin Patrick (SVP, CFO & Treasurer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 32,700 shares
@ $0
Granted 77,500 options to buy
@ $7.05, valued at
$546.4k
|
|
| 02/21/2023 |
4
| Birznieks Gunther (SVP, Business Development) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 32,700 shares
@ $0
Granted 77,500 options to buy
@ $7.05, valued at
$546.4k
|
|
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/29/2022 |
4
| Birznieks Gunther (SVP, Business Development) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Exercised 1,250 options to buy
@ $3.12, valued at
$3.9k
|
|
| 08/23/2022 |
4
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 3,605 shares
@ $10.2656, valued at
$37k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2022 |
4
| Moran Kevin Patrick (SVP, CFO & Treasurer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 2,239 shares
@ $10.97, valued at
$24.6k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Mitchell Stephen Ray (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 12,006 shares
@ $0
Granted 24,707 options to buy
@ $9.37, valued at
$231.5k
|
|
| 06/21/2022 |
4
| DUGAN RICHARD W (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 12,006 shares
@ $0
Granted 24,707 options to buy
@ $9.37, valued at
$231.5k
|
|
| 06/21/2022 |
4
| Chrousos Phaedra (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 12,006 shares
@ $0
Granted 24,707 options to buy
@ $9.37, valued at
$231.5k
|
|
| 06/14/2022 |
4
| Mitchell Stephen Ray (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 2,700 shares
@ $9.4789, valued at
$25.6k
|
|
| 06/03/2022 |
4
| Watkins Thomas (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 6,441 shares
@ $9.902, valued at
$63.8k
Exercised 15,000 options to buy
@ $4.15, valued at
$62.3k
|
|
| 06/02/2022 |
4
| DUGAN RICHARD W (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 6,500 shares
@ $9.8542, valued at
$64.1k
Exercised 15,000 options to buy
@ $4.15, valued at
$62.3k
|
|
|